Resistance Analyses of Integrase Strand Transfer Inhibitors within Phase 3 Clinical Trials of Treatment-Naive Patients

The integrase (IN) strand transfer inhibitors (INSTIs), raltegravir (RAL), elvitegravir (EVG) and dolutegravir (DTG), comprise the newest drug class approved for the treatment of HIV-1 infection, which joins the existing classes of reverse transcriptase, protease and binding/entry inhibitors. The ef...

Descripción completa

Detalles Bibliográficos
Autores principales: White, Kirsten L., Raffi, Francois, Miller, Michael D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4113796/
https://www.ncbi.nlm.nih.gov/pubmed/25054884
http://dx.doi.org/10.3390/v6072858

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4113796/
https://www.ncbi.nlm.nih.gov/pubmed/25054884
http://dx.doi.org/10.3390/v6072858

Ejemplares similares